|
|
 |
|
Viewing report
|
|
 |
Advanced Cell Technology Inc (26-Jan-2012)
Directors Deals Ltd, Jan 2012, Pages: 1
Robert Lanza, (PDMR) Chief Scientific Officer of Advanced Cell Technology Inc [market cap £168million] sold 7,658,300 shares at 0.175USD, holding is now 58,573,450 shares; representing 3.434 percent of the shares on issue. Holding has decreased 23 percent, the total trade value was £933,869 and the significance rating is 73/100.
Directors Deals monitors and analyses share transactions made by directors in the shares of their own company. We monitor 18,000 companies share transactions in 46 countries worldwide (32 in Europe, 7 in Asia, 2 in North America, 2 in Oceania, 2 in the Middle East & 2 in Africa).
|
 |
|
|